Rosett Max 4
4 · Immunome Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Rosett Max
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2024-01-31+175,000→ 175,000 totalExercise: $16.57Exp: 2034-01-30→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.